Compass Financial Advisors LLC Bristol Myers Squibb CO Transaction History

Compass Financial Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	SELL	$65.71 - $74.53 $71,821 - $81,461	-1,093 Reduced 5.33%	19,407 $1.35 Million
Q4 2022 Feb 06, 2023	SELL	$68.48 - $81.09 $28,556 - $33,814	-417 Reduced 1.99%	20,500 $1.47 Million
Q3 2022 Nov 09, 2022	BUY	$0.13 - $76.84 $1 - $1,152	15 Added 0.07%	20,917 $1.49 Million
Q2 2022 Aug 08, 2022	SELL	$72.62 - $79.98 $38,488 - $42,389	-530 Reduced 2.47%	20,902 $1.61 Million
Q1 2022 May 05, 2022	BUY	$61.48 - $73.72 $22,624 - $27,128	368 Added 1.75%	21,432 $1.57 Million
Q4 2021 Feb 24, 2022	BUY	$53.63 - $62.52 $1.13 Million - $1.32 Million	21,064 New	21,064 $1.31 Million

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Compass Financial Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Compass Financial Advisors LLC with notifications on news.